The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Klemenova I.A.

Volga Federal Medical Research Center, Health Ministry of Russia, Nizhny Novgorod, Russia

Esenin S.A.

Nizhegorodskiĭ nauchno-issledovatel'skiĭ kozhno-venerologicheskiĭ institut Minzdravsotsrazvitiia Rossiĭskoĭ Federatsii

Evolution of the application of glucocorticosteroid preparations for the local treatment in dermatological practice

Authors:

Klemenova I.A., Esenin S.A.

More about the authors

Read: 7016 times


To cite this article:

Klemenova IA, Esenin SA. Evolution of the application of glucocorticosteroid preparations for the local treatment in dermatological practice. Russian Journal of Clinical Dermatology and Venereology. 2011;9(5):46‑50. (In Russ.)

Recommended articles:

References:

  1. Belousova T.A., Lukashova N.N. Differentsirovannyi podkhod k vyboru naruzhnykh glyukokortikosteroidov v terapii dermatozov. Klin dermatol i venerol 2006; 3: 74-78.
  2. Albrecht G. Clinical comparision of methylprednizolone aceponate and prednicarbate in chronic eczema. J Eur Acad Dermatol Venerol 1994; 3: Suppl 1: 42-48.
  3. Bieber T., Vick K., Folster-Holst R. et al. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. Allergy 2007; 62: 2: 184-189.
  4. Fritsch P. Clinical experience with Methylprednisolone aceponate (MPA) in eczem. J Dermatol Treat 1992; 3: Suppl 2: 17-19.
  5. Haneke E. The treatment of atopic dermatitis with methylprednizolone aceponate (MPA), a new topical corticosteroid. J Dermatol Treat 1992; 3: Suppl 2: 13-15.
  6. Luger T.A. Topische Dermatotherapie mit Glukokortikoiden - Therapeutischer index. Leitlinie Deutsch Dermatol Gesellschaft 2004; 7: 629-634.
  7. Mori M., Pimpinelli N., Gianotti B. Topical corticosteroids and unwanted local effects: improving the benefit/risk ratio. Drug Safety 1994; 10: 5: 406-412.
  8. Ruzicka T. Methylprednisolone aceponate in eczema and other inflammatory skin disorders - a clinical update. Int J Clin Pract 2006; 60: 1: 85-92.
  9. Zaumseil R.P., Fuhrman H., Kecskes A. et al. Methylprednisolone aceponate (Ad-vantan) - an effective topical corticoid therapy with few side effects. Jabrbuch Dermatol 1992; 3: 247-263.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.